ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for acetaminophen; propoxyphene hydrochloride and what is the scope of freedom to operate?
Acetaminophen; propoxyphene hydrochloride
is the generic ingredient in four branded drugs marketed by Aaipharma Llc, Lederle, Mylan, Sandoz, Vintage Pharms, Watson Labs, and Caraco, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.Summary for ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 7 |
NDAs: | 8 |
Clinical Trials: | 5 |
DailyMed Link: | ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mansoura University | Phase 1/Phase 2 |
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
See all ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE clinical trials
US Patents and Regulatory Information for ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN | acetaminophen; propoxyphene hydrochloride | TABLET;ORAL | 089959-001 | Jul 18, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lederle | DOLENE AP-65 | acetaminophen; propoxyphene hydrochloride | TABLET;ORAL | 085100-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan | PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN | acetaminophen; propoxyphene hydrochloride | TABLET;ORAL | 083978-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |